Filing metadata

Accession number
0000899243-21-016975
Form type
Form 3
Filer
A2A Pharmaceuticals, Inc.
CIK
CIK 1859061
Filed
Apr 26, 2021
Reporting period
Apr 15, 2021
Description
Initial ownership

Explore SEC Filings Hub